Restaging With Prostate-Specific Membrane Antigen Imaging in Metastatic Castration-Resistant Prostate Cancer: When Seeing More Is Detrimental to Care

被引：3
|
作者：
Madan, Ravi A. [1 ]
Yu, Evan Y. [2 ,3 ]
Posadas, Edwin M. [4 ]
Lee, Richard J. [5 ]
Karzai, Fatima [1 ]
Choyke, Peter L. [6 ]
机构：
[1] NCI, Genitourinary Malignancies Branch, Bethesda, MD 20814 USA
[2] Univ Washington, Seattle, WA USA
[3] Fred Hutchinson Canc Ctr, Seattle, WA USA
[4] Cedars Sinai Med Ctr, Samuel Oschin Comprehens Canc Inst, Los Angeles, CA USA
[5] Harvard Med Sch, Massachusetts Gen Hosp Canc Ctr, Dept Med, Boston, MA USA
[6] NCI, Mol Imaging Branch, Bethesda, MD USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 19期
关键词：
D O I：
10.1200/JCO.23.02727
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
#PSMA is amazing new tech but is using it to expedite the call of disease progression helping #ProstateCancer patients?
引用
收藏
页数：4
相关论文
共 50 条
  • [1] Prostate-Specific Membrane Antigen Uptake and Survival in Metastatic Castration-Resistant Prostate Cancer
    Vlachostergios, Panagiotis J.
    Niaz, Muhammad Junaid
    Sun, Michael
    Mosallaie, Seyed Ali
    Thomas, Charlene
    Christos, Paul J.
    Osborne, Joseph R.
    Molina, Ana M.
    Nanus, David M.
    Bander, Neil H.
    Tagawa, Scott T.
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [2] Prostate-specific Membrane Antigen-based Imaging of Castration-resistant Prostate Cancer
    Weber, Manuel
    Hadaschik, Boris
    Ferdinandus, Justin
    Rahbar, Kambiz
    Beogemann, Martin
    Herrmann, Ken
    Fendler, Wolfgang P.
    Kesch, Claudia
    EUROPEAN UROLOGY FOCUS, 2021, 7 (02): : 279 - 287
  • [3] Prostate-Specific Membrane Antigen-Directed Therapy for Metastatic Castration-Resistant Prostate Cancer
    Teo, Min Yuen
    Morris, Michael J.
    CANCER JOURNAL, 2016, 22 (05): : 347 - 352
  • [4] Narrative review: prostate-specific membrane antigen-radioligand therapy in metastatic castration-resistant prostate cancer
    Lunger, Lukas
    Tauber, Robert
    Feuerecker, Benedikt
    Gschwend, Jurgen E.
    Eiber, Matthias
    Heck, Matthias M.
    TRANSLATIONAL ANDROLOGY AND UROLOGY, 2021, 10 (10) : 3963 - 3971
  • [5] Characterizing Prostate-Specific Antigen Levels at Death in Patients with Metastatic Castration-Resistant Prostate Cancer: Are We Underutilizing Imaging?
    Bikkasani, Krishna
    Qin, Qian
    Zhong, Xiaobo
    Lin, Justin
    Galsky, Matthew D.
    Oh, William K.
    Tsao, Che-Kai
    CLINICAL GENITOURINARY CANCER, 2021, 19 (06) : E346 - E351
  • [6] Dramatic prostate-specific antigen response with activated hemicellulose compound in metastatic castration-resistant prostate cancer
    Turner, Jeffrey
    Chaudhary, Uzair
    ANTI-CANCER DRUGS, 2009, 20 (03) : 215 - 216
  • [7] Current role of prostate-specific membrane antigen-based imaging and radioligand therapy in castration-resistant prostate cancer
    Chen, Jiaxian
    Qi, Lin
    Tang, Yongxiang
    Tang, Guyu
    Gan, Yu
    Cai, Yi
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2022, 10
  • [8] Prostate-specific antigen testing in men with metastatic castration-resistant prostate cancer treated with docetaxel chemotherapy
    Tsai, Yuh-Shyan
    Tzai, Tzong-Shin
    UROLOGICAL SCIENCE, 2015, 26 (04) : 277 - 277
  • [9] Imaging expression of prostate-specific membrane antigen and response to PSMA-targeted β-emitting radionuclide therapies in metastatic castration-resistant prostate cancer
    Vlachostergios, Panagiotis J.
    Niaz, Muhammad Junaid
    Skafida, Myrto
    Mosallaie, Seyed Ali
    Thomas, Charlene
    Christos, Paul J.
    Osborne, Joseph R.
    Molina, Ana M.
    Nanus, David M.
    Bander, Neil Harrison
    Tagawa, Scott T.
    PROSTATE, 2021, 81 (05): : 279 - 285
  • [10] Preliminary results of targeted prostate-specific membrane antigen imaging in evaluating the efficacy of a novel hormone agent in metastatic castration-resistant prostate cancer
    Liu, Chang
    Zhu, Yao
    Su, Hengchuan
    Xu, Xiaoping
    Zhang, Yingjian
    Song, Shaoli
    Wang, Beihe
    Ye, Dingwei
    Hu, Silong
    CANCER MEDICINE, 2020, 9 (10): : 3278 - 3286
12345